COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

Transdermal buprenorphine for the treatment of radiation induced mucositis pain in head & neck cancer patients: A pilot study

Protocol No
IIT-SHREENIVAS-BUPRENORPHINE
Principal Investigator
Aditya Shreenivas
Phase
II
Summary
This project is being done to investigate the efficacy of using FDA approved doses of a Buprenorphine patch in combination with oral Tramadol to provide adequate pain control in radiation induced mucositis
Description
Transdermal buprenorphine for the treatment of radiation induced mucositis pain in head & neck cancer patients: A pilot study
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Sub Category